admp stock price
Adamis Pharmaceuticals Corporation (ADMP) has been on the move lately as the stock has risen by 21% in the past four weeks, and it is currently trading well above its 20-Day SMA. For US Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. Most Recent Earnings figures are based on Non-GAAP income from continuing operations. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. 52 Week High/Low 52 Week High is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period. 52 Week Low is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period. $ 10.98 / $ 2.40. Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months. Analysts' Ratings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Adamis Pharmaceuticals (ADMP) Stock Plummeting on FDA Drug Rejection. Adamis Pharmaceuticals' (ADMP) stock is down as the FDA wants further testing of the company's emergency allergy drug before giving approval. Adamis Pharmaceuticals Corporation (ADMP) has been on the move lately as the stock has risen by 21% in the past four weeks, and it is currently trading well above its 20-Day SMA. Adamis Pharmaceuticals Corp trades on the NASDAQ under the ticker symbol ADMP.. 2 brokerages have issued 12-month target prices for Adamis Pharmaceuticals Corp's shares. Their forecasts range from $5.00 to $10.00. On average, they expect Adamis Pharmaceuticals Corp's stock price to reach $7.50 in the next year. Pharma Has History of Price Gouging, Mylan Should Be No Surprise. While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost. Here's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Soaring Today. Adamis Pharmaceuticals (ADMP) could benefit from rival Mylan's (MYL) high price of EpiPens as its own product is reportedly close to approval. Adamis Pharmaceuticals Corporation is a bio-pharmaceuticals company. The Company develops and distributes specialty pharmaceutical products in the therapeutic areas of oncology, immunology, infectious diseases, allergy and respiratory. Adamis Pharmaceuticals offers its products to the healthcare industry.
$7.50